The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure ...
Biobeat Technologies has raised $50 million in a series B round to help boost the commercialization of its blood pressure ...
Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA ...
This certification was granted for the entire 'CART PLATFORM,' centered on the ring-type medical device equipped with ...
A pilot program between RWJBarnabas Health and the Liberty Science Center‘s SciTech Scity Healthcare Innovation Engine is showing the vast potential of digital health solutions. Biobeat, a medtech ...
Huawei is reportedly preparing to introduce its next smartwatch in India. According to recent leaks, the upcoming wearable may include advanced health tracking features not commonly seen on wrist ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Baxdrostat reduced 24-hour ambulatory blood pressure in ...
Dear L.L.: Home blood pressure monitoring adds a great deal of information to in-office blood pressure monitoring, since it ensures that the blood pressure is being optimally controlled. A few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback